Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-188738
Filing Date
2014-05-08
Accepted
2014-05-08 07:42:50
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d702395d10q.htm 10-Q 507143
2 EX-31.1 d702395dex311.htm EX-31.1 6745
3 EX-31.2 d702395dex312.htm EX-31.2 6782
4 EX-32.1 d702395dex321.htm EX-32.1 3473
5 EX-32.2 d702395dex322.htm EX-32.2 3538
  Complete submission text file 0001193125-14-188738.txt   3375368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT drtx-20140331.xml EX-101.INS 353558
7 XBRL TAXONOMY EXTENSION SCHEMA drtx-20140331.xsd EX-101.SCH 36893
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drtx-20140331_cal.xml EX-101.CAL 49559
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drtx-20140331_def.xml EX-101.DEF 106979
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE drtx-20140331_lab.xml EX-101.LAB 318825
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drtx-20140331_pre.xml EX-101.PRE 212610
Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Filer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35599 | Film No.: 14822979
SIC: 2834 Pharmaceutical Preparations